Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Obstructive Lung Diseases

Free Subscription 28.11.2022 1 Allergy 1 Am J Respir Crit Care Med 1 Arch Bronconeumol 1 Arch Dis Child 1 Eur Respir J 6 J Asthma 3 J Investig Allergol Clin Immunol 1 JAMA 4 Pediatr Pulmonol 3 PLoS One 2 Respir Med 4 Respir Res 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. MUSIOL S, Harris CP, Karlina R, Gostner JM, et al
   Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice.
   Allergy. 2022 Nov 24. doi: 10.1111/all.15589.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

2. MURPHY RC, Morrell ED, Hallstrand TS
   The Intersection Between Autoimmunity, Macrophage Dysfunction, Endotype and Exacerbations in Severe Asthma.
   Am J Respir Crit Care Med. 2022 Nov 22. doi: 10.1164/rccm.202211-2074.
   PubMed        
   
   

   
   Arch Bronconeumol

3. MADRID CARBAJAL C, Palomo B, Garcia Clemente M
   Radiological Changes After Treatment With Triple Therapy in Cystic Fibrosis. Are Bronchiectasis Irreversible?
   Arch Bronconeumol. 2022 Nov 5:S0300-2896(22)00599.
   PubMed        
   
   

   
   Arch Dis Child

4. VALENCIA-RAMOS J, Ochoa Sangrador C, Garcia M, Oyaguez P, et al
   Impact of different nebulisation systems on patient comfort in bronchiolitis: a randomised controlled cross-over trial.
   Arch Dis Child. 2022;107:1122-1127.
   PubMed         Abstract available
   
   

   
   Eur Respir J

5. MENDY A, Merianos AL, Mersha TB, Mahabee-Gittens EM, et al
   Blood volatile organic compounds associated with non-reversible and reversible airflow obstruction in US adults.
   Eur Respir J. 2022;60:2201185.
   PubMed        
   
   

   
   J Asthma

6. BICKEL S, Cohen RT, Needleman JP, Volerman A, et al
   Appropriate Inhaler Use in Children with Asthma: Barriers and Opportunities through the Lens of the Socio-Ecological Model.
   J Asthma. 2022 Nov 23:1-14. doi: 10.1080/02770903.2022.2152352.
   PubMed         Abstract available
   
   
7. STARR S, Wysocki M, DeLeon JD, Silverstein G, et al
   Obesity-related pediatric asthma: relationships between pulmonary function and clinical outcomes.
   J Asthma. 2022 Nov 23:1-14. doi: 10.1080/02770903.2022.2152351.
   PubMed         Abstract available
   
   
8. ANCHETA AJ, Cunningham PB, Liu J, Powell JS, et al
   Asthma is Associated with Bullying Victimization in Rural Adolescents.
   J Asthma. 2022 Nov 22:1-14. doi: 10.1080/02770903.2022.2151466.
   PubMed         Abstract available
   
   
9. OU X, Fang Z, Li W, Xia Y, et al
   Novel role for integrin beta4 in asthmatic children infected with Mycoplasma pneumoniae.
   J Asthma. 2022 Nov 21:1-22. doi: 10.1080/02770903.2022.2149932.
   PubMed         Abstract available
   
   
10. KAN A, Sen V
    The use of puzzles in inhaler technique training.
    J Asthma. 2022;59:2413-2420.
    PubMed         Abstract available
    
    
11. FOX CW, Khaw CL, Gerke AK, Lund BC, et al
    Montelukast and neuropsychiatric events - a sequence symmetry analysis.
    J Asthma. 2022;59:2360-2366.
    PubMed         Abstract available
    
    

    
    J Investig Allergol Clin Immunol

12. CASTILLA-MARTINEZ M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, et al
    Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0872.
    PubMed        
    
    
13. DOMINGO C, Sicras-Mainar A, Sicras-Navarro A, Sogo A, et al
    Prevalence, T2-biomarkers and cost of severe asthma in the era of biologics: The BRAVO-1 study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0871.
    PubMed         Abstract available
    
    
14. HERRERA-LUIS E, Forno E, Celedon JC, Pino-Yanes M, et al
    Asthma exacerbations: the genes behind the scenes.
    J Investig Allergol Clin Immunol. 2022 Nov 24:0. doi: 10.18176/jiaci.0878.
    PubMed         Abstract available
    
    

    
    JAMA

15. EKSTROM M, Ferreira D, Chang S, Louw S, et al
    Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
    JAMA. 2022;328:2022-2032.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

16. BUENDIA JA, Feliciano-Alfonso JE, Florez ID
    Systematic review and cost-utility of high flow nasal cannula versus continuous positive airway pressure in children with acute severe or moderate bronchiolitis in Colombia.
    Pediatr Pulmonol. 2022;57:3111-3118.
    PubMed         Abstract available
    
    
17. LAIRD P, Ball N, Brahim S, Brown H, et al
    Prevalence of chronic respiratory diseases in Aboriginal children: A whole population study.
    Pediatr Pulmonol. 2022;57:3136-3144.
    PubMed         Abstract available
    
    
18. TARANTINO L, Goodrich N, Kerns E, McCulloh R, et al
    Is implementation of a hospital pathway for high-flow nasal cannula initiation and weaning associated with reduced high-flow duration in bronchiolitis?
    Pediatr Pulmonol. 2022;57:2971-2980.
    PubMed         Abstract available
    
    
19. ZIOGA A, Fouzas S, Kostara M, Domouzoglou E, et al
    A rare case of hypereosinophilic obliterative bronchiolitis in an adolescent girl.
    Pediatr Pulmonol. 2022;57:3180-3182.
    PubMed        
    
    

    
    PLoS One

20. BREULS S, Pereira de Araujo C, Blondeel A, Yserbyt J, et al
    Physical activity pattern of patients with interstitial lung disease compared to patients with COPD: A propensity-matched study.
    PLoS One. 2022;17:e0277973.
    PubMed         Abstract available
    
    
21. ZHENG J, Zhang Z, Han R, Zhang H, et al
    Effects of exercise-based home pulmonary rehabilitation on patients with chronic obstructive pulmonary disease: An overview of systematic review.
    PLoS One. 2022;17:e0277632.
    PubMed         Abstract available
    
    
22. ABE T, Yoshida N, Shimada T, Nakashima M, et al
    Respiratory frequency-tunable dynamic imaging for lung function: New exam method using chest X-ray cine imaging considering various respiratory diseases.
    PLoS One. 2022;17:e0276859.
    PubMed         Abstract available
    
    

    
    Respir Med

23. ALIBERTI S, Gramegna A, Zucchetti S, Simonetta E, et al
    Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy.
    Respir Med. 2022;205:107056.
    PubMed        
    
    
24. RYAN D, Keighley A, Jackson T
    Patient perspectives in asthma: Listening to and learning from a new paradigm in translational research.
    Respir Med. 2022;205:107013.
    PubMed        
    
    

    
    Respir Res

25. LI W, Wang B, Tan M, Song X, et al
    Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
    Respir Res. 2022;23:321.
    PubMed         Abstract available
    
    
26. FEIZI H, Alizadeh M, Nejadghaderi SA, Noori M, et al
    The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
    Respir Res. 2022;23:319.
    PubMed         Abstract available
    
    
27. MA L, Zhu M, Li G, Gai J, et al
    Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
    Respir Res. 2022;23:316.
    PubMed         Abstract available
    
    
28. WANG WW, Mao B, Liu Y, Gu SY, et al
    Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.
    Respir Res. 2022;23:317.
    PubMed         Abstract available
    
    

    
    Thorax

29. TYDEMAN F, Pfeffer PE, Vivaldi G, Holt H, et al
    Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).
    Thorax. 2022 Nov 23:thorax-2022-219591. doi: 10.1136/thorax-2022-219591.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: